1. Burra P, Freeman R. Trends in liver transplantation 2011. J Hepatol 2012;56 Suppl 1:S101-111.
2. Uemoto S, Fujimoto Y, Teratani T et al. Introduction of Mesenchymal Stem Cells for Liver Surgery (Hepatectomy and Transplantation). In: Nakao K, Minato N, Uemoto S, (eds). Innovative Medicine: Basic Research and Development. Tokyo: Springer Copyright 2015, The Author(s). 2015: 281-293.
3. Kim PTW, Testa G. Living donor liver transplantation in the USA. Hepatobiliary surgery and nutrition 2016;5(2):133-140.
4. Sudhindran S, Menon RN, Balakrishnan D. Challenges and Outcome of Left-lobe Liver Transplants in Adult Living Donor Liver Transplants. J Clin Exp Hepatol 2012;2(2):181-187.
5. Shoreem H, Gad EH, Soliman H et al. Small for size syndrome difficult dilemma: Lessons from 10 years single centre experience in living donor liver transplantation. World J Hepatol 2017;9(21):930-944.
6. Wang HS, Ohkohchi N, Enomoto Y et al. Excessive portal flow causes graft failure in extremely small-for-size liver transplantation in pigs. World J Gastroenterol 2005;11(44):6954-6959.
7. Gruttadauria S, Mandala L, Miraglia R et al. Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series. Clin Transplant 2007;21(6):761-766.
8. Humar A, Beissel J, Crotteau S et al. Delayed splenic artery occlusion for treatment of established small-for-size syndrome after partial liver transplantation. Liver Transpl 2009;15(2):163-168.
9. Macshut M, Kaido T, Yao S et al. Older donor age is a risk factor for negative outcomes after adult living donor liver transplantation using small-for- size grafts. Liver Transpl 2019.
10. Kinaci E, Kayaalp C. Portosystemic Shunts for "Too Small-for-Size Syndrome" After Liver Transplantation: A Systematic Review. World J Surg 2016;40(8):1932-1940.
11. Yagi S, Iida T, Hori T et al. Effect of Portal Haemodynamics on Liver Graft and Intestinal Mucosa after Small-for-Size Liver Transplantation in Swine. Eur Surg Res 2012;48(3):163-170.
12. Troisi R, Ricciardi S, Smeets P et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant 2005;5(6):1397-1404.
13. Kelly DM, Demetris AJ, Fung JJ et al. Porcine partial liver transplantation: A novel model of the “small-for-size” liver graft. Liver Transpl 2004;10(2):253-263.
14. Demetris AJ, Kelly DM, Eghtesad B et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 2006;30(8):986-993.
15. Poisson J, Lemoinne S, Boulanger C et al. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol 2017;66(1):212-227.
16. Tanaka H, Hashizume K, Enosawa S et al. Successful transplantation of a 20% partial liver graft in rats: a technical innovation. J Surg Res 2003;110(2):409-412.
17. Kubota T, Takabe K, Yang M et al. Minimum sizes for remnant and transplanted livers in rats. J Hepatobiliary Pancreat Surg 1997;4(4):398-404.
18. Yamanaka K, Hatano E, Narita M et al. Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model. Liver Transpl 2011;17(1):60-69.
19. Ptw K, Gb K. Importance of Hepatic Flows in Liver Transplantation. Journal of Hepatology and Gastrointestinal disorders 2016;02(02).
20. Ito T, Kiuchi T, Yamamoto H et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation 2003;75(8):1313-1317.
21. Dezawa M. Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration. Cell Transplant 2016;25(5):849-861.
22. Wakao S, Kitada M, Kuroda Y et al. Multilineage-differentiating stress- enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci 2011;108(24):9875-9880.
23. Yamada Y, Wakao S, Kushida Y et al. S1P-S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial Infarction. Circ Res 2018;122(8):1069-1083.
24. Iseki M, Kushida Y, Wakao S et al. Muse Cells, Nontumorigenic Pluripotent-Like Stem Cells, Have Liver Regeneration Capacity Through Specific Homing and Cell Replacement in a Mouse Model of Liver Fibrosis. Cell Transplant 2017;26(5):821-840.
25. Katagiri H, Kushida Y, Nojima M et al. A Distinct Subpopulation of Bone Marrow Mesenchymal Stem Cells, Muse Cells, Directly Commit to the Replacement of Liver Components. Am J Transplant 2016;16(2):468-483.
26. Hosoyama K, Wakao S, Kushida Y et al. Intravenously injected human multilineage-differentiating stress-enduring cells selectively engraft into mouse aortic aneurysms and attenuate dilatation by differentiating into multiple cell types. J Thorac Cardiovasc Surg 2018;155(6):2301-2313 e2304.
27. Yabuki H, Wakao S, Kushida Y et al. Human Multilineage-differentiating Stress-Enduring Cells Exert Pleiotropic Effects to Ameliorate Acute Lung Ischemia-Reperfusion Injury in a Rat Model. Cell Transplant 2018;27(6):979-993.
28. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979;28(1):47-50.
29. Sato Y, Farges O, Akpinar E et al. An easy and physiologic arterial reconstruction method (sleeve technique) for orthotopic rat liver transplantation. Transplant Proc 1996;28(6):3649-3651.
30. de Graaf W, Bennink RJ, Heger M et al. Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med 2011;52(2):294-302.
31. Saito K, Chang YF, Horikawa K et al. Luminescent proteins for high- speed single-cell and whole-body imaging. Nat Commun 2012;3:1262.
32. Susaki EA, Tainaka K, Perrin D et al. Whole-brain imaging with single- cell resolution using chemical cocktails and computational analysis. Cell 2014;157(3):726-739.
33. Grugan KD, Miller CG, Yao Y et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci U S A 2010;107(24):11026-11031.
34. Chen J, Sun X, Shao R et al. VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer. Int J Nanomedicine 2017;12:6075-6088.
35. Kuroda Y, Kitada M, Wakao S et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci 2010;107(19):8639-8643.
36. LeCouter J, Moritz DR, Li B et al. Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1. Science 2003;299(5608):890-893.
37. Olmedilla L, Lisbona CJ, Perez-Pena JM et al. Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation. Transplantation 2016;100(3):613-620.
38. Sugimoto H, Okochi O, Hirota M et al. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye- densitometry. J Hepatobiliary Pancreat Surg 2006;13(6):543-548.
39. Faybik P, Krenn C-G, Baker A et al. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: A prospective investigator-blinded study. Liver Transpl 2004;10(8):1060-1064.
40. Avery MB, Belanger BL, Bromley A et al. Mesenchymal Stem Cells Exhibit Both a Proinflammatory and Anti-Inflammatory Effect on Saccular Aneurysm Formation in a Rabbit Model. Stem Cells Int 2019;2019:15.
41. Abarbanell AM, Coffey AC, Fehrenbacher JW et al. Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann Thorac Surg 2009;88(3):1036-1043.
42. Ishii T, Sato M, Sudo K et al. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem 1995;117(5):1105-1112.
43. Bockhorn M, Goralski M, Prokofiev D et al. VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res 2007;138(2):291-299.
44. Adas G, Koc B, Adas M et al. Effects of mesenchymal stem cells and VEGF on liver regeneration following major resection. Langenbecks Arch Surg 2016;401(5):725-740.
45. Zhang Y, Li R, Rong W et al. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4- induced hepatocirrhosis. Cell Death Dis 2018;9(12):1186.
46. Ma T, Liu H, Chen W et al. Implanted adipose-derived stem cells attenuate small-for-size liver graft injury by secretion of VEGF in rats. Am J Transplant 2012;12(3):620-629.
47. Man K, Lo C-M, Ng IO-L et al. Liver Transplantation in Rats Using Small- for-Size Grafts: A Study of Hemodynamic and Morphological Changes. Arch Surg 2001;136(3):280-285.
論文の公開元へ
